Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs

MV Similon; C Paasche; F Krol; B Lerer; GM Goodwin; M Berk; A Meyer-Lindenberg; TA Ketter; LN Yatham; JF Goldberg; GS Malhi; R El-Mallakh; RW Licht; AH Young; F Kapczinski; M Swartz; M Hagin; C Torrent; A Serretti; A Yildiz; A Martinez-Aran; S Strejilevich; J Rybakowski; G Sani; Heinz Grunze; G Vazquez; AG Pinto; JM Azorin; W Nolen; O Sentissi; C Lopez-Jaramillo; BN Frey; A Nierenberg; G Parker; DJ Bond; A Cohen; A Tortorella; G Perugi; E Vieta; D Popovic

doi:10.1016/j.euroneuro.2022.05.002

Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs

MV Similon, C Paasche, F Krol, B Lerer, GM Goodwin, M Berk, A Meyer-Lindenberg, TA Ketter, LN Yatham, JF Goldberg, GS Malhi, R El-Mallakh, RW Licht, AH Young, F Kapczinski, M Swartz, M Hagin, C Torrent, A Serretti, A YildizA Martinez-Aran, S Strejilevich, J Rybakowski, G Sani, Heinz Grunze (Co-author), G Vazquez, AG Pinto, JM Azorin, W Nolen, O Sentissi, C Lopez-Jaramillo, BN Frey, A Nierenberg, G Parker, DJ Bond, A Cohen, A Tortorella, G Perugi, E Vieta, D Popovic

Klinikum am Weissenhof, Zentrum für Psychiatrie Schwäbisch Hall

Research output: Contribution to journal › Original Article › peer-review

8 Citations (Web of Science)

Original language	English
Pages (from-to)	91-99
Journal	EUROPEAN NEUROPSYCHOPHARMACOLOGY
Volume	60
DOIs	https://doi.org/10.1016/j.euroneuro.2022.05.002
Publication status	Published - 2022

Keywords

ACTIVE-CONTROL TRIALS
PLACEBO-CONTROLLED TRIALS
ISSUES
ETHICS
SUICIDE

Access to Document

10.1016/j.euroneuro.2022.05.002

Cite this

Similon, MV., Paasche, C., Krol, F., Lerer, B., Goodwin, GM., Berk, M., Meyer-Lindenberg, A., Ketter, TA., Yatham, LN., Goldberg, JF., Malhi, GS., El-Mallakh, R., Licht, RW., Young, AH., Kapczinski, F., Swartz, M., Hagin, M., Torrent, C., Serretti, A., ... Popovic, D. (2022). Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs. EUROPEAN NEUROPSYCHOPHARMACOLOGY , 60, 91-99. https://doi.org/10.1016/j.euroneuro.2022.05.002

Similon, MV ; Paasche, C ; Krol, F et al. / Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs. In: EUROPEAN NEUROPSYCHOPHARMACOLOGY 2022 ; Vol. 60. pp. 91-99.

@article{d26011359cf542e6a725523dc10a99a3,

title = "Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs",

keywords = "ACTIVE-CONTROL TRIALS, PLACEBO-CONTROLLED TRIALS, ISSUES, ETHICS, SUICIDE",

author = "MV Similon and C Paasche and F Krol and B Lerer and GM Goodwin and M Berk and A Meyer-Lindenberg and TA Ketter and LN Yatham and JF Goldberg and GS Malhi and R El-Mallakh and RW Licht and AH Young and F Kapczinski and M Swartz and M Hagin and C Torrent and A Serretti and A Yildiz and A Martinez-Aran and S Strejilevich and J Rybakowski and G Sani and Heinz Grunze and G Vazquez and AG Pinto and JM Azorin and W Nolen and O Sentissi and C Lopez-Jaramillo and BN Frey and A Nierenberg and G Parker and DJ Bond and A Cohen and A Tortorella and G Perugi and E Vieta and D Popovic",

note = "Lehr-KH Schw{\"a}bisch-Hall: Grunze: Psychiatrie Schw{\"a}bisch Hall & Paracelsus Medical University, Nuremberg, Germany",

year = "2022",

doi = "10.1016/j.euroneuro.2022.05.002",

language = "English",

volume = "60",

pages = "91--99",

journal = "EUROPEAN NEUROPSYCHOPHARMACOLOGY ",

issn = "0924-977X",

}

Similon, MV, Paasche, C, Krol, F, Lerer, B, Goodwin, GM, Berk, M, Meyer-Lindenberg, A, Ketter, TA, Yatham, LN, Goldberg, JF, Malhi, GS, El-Mallakh, R, Licht, RW, Young, AH, Kapczinski, F, Swartz, M, Hagin, M, Torrent, C, Serretti, A, Yildiz, A, Martinez-Aran, A, Strejilevich, S, Rybakowski, J, Sani, G, Grunze, H, Vazquez, G, Pinto, AG, Azorin, JM, Nolen, W, Sentissi, O, Lopez-Jaramillo, C, Frey, BN, Nierenberg, A, Parker, G, Bond, DJ, Cohen, A, Tortorella, A, Perugi, G, Vieta, E & Popovic, D 2022, 'Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs', EUROPEAN NEUROPSYCHOPHARMACOLOGY , vol. 60, pp. 91-99. https://doi.org/10.1016/j.euroneuro.2022.05.002

Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs. / Similon, MV; Paasche, C; Krol, F et al.
In: EUROPEAN NEUROPSYCHOPHARMACOLOGY , Vol. 60, 2022, p. 91-99.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs

AU - Similon, MV

AU - Paasche, C

AU - Krol, F

AU - Lerer, B

AU - Goodwin, GM

AU - Berk, M

AU - Meyer-Lindenberg, A

AU - Ketter, TA

AU - Yatham, LN

AU - Goldberg, JF

AU - Malhi, GS

AU - El-Mallakh, R

AU - Licht, RW

AU - Young, AH

AU - Kapczinski, F

AU - Swartz, M

AU - Hagin, M

AU - Torrent, C

AU - Serretti, A

AU - Yildiz, A

AU - Martinez-Aran, A

AU - Strejilevich, S

AU - Rybakowski, J

AU - Sani, G

AU - Grunze, Heinz

AU - Vazquez, G

AU - Pinto, AG

AU - Azorin, JM

AU - Nolen, W

AU - Sentissi, O

AU - Lopez-Jaramillo, C

AU - Frey, BN

AU - Nierenberg, A

AU - Parker, G

AU - Bond, DJ

AU - Cohen, A

AU - Tortorella, A

AU - Perugi, G

AU - Vieta, E

AU - Popovic, D

N1 - Lehr-KH Schwäbisch-Hall: Grunze: Psychiatrie Schwäbisch Hall & Paracelsus Medical University, Nuremberg, Germany

PY - 2022

Y1 - 2022

KW - ACTIVE-CONTROL TRIALS

KW - PLACEBO-CONTROLLED TRIALS

KW - ISSUES

KW - ETHICS

KW - SUICIDE

U2 - 10.1016/j.euroneuro.2022.05.002

DO - 10.1016/j.euroneuro.2022.05.002

M3 - Original Article

C2 - 35665655

SN - 0924-977X

VL - 60

SP - 91

EP - 99

JO - EUROPEAN NEUROPSYCHOPHARMACOLOGY

JF - EUROPEAN NEUROPSYCHOPHARMACOLOGY

ER -

Similon MV, Paasche C, Krol F, Lerer B, Goodwin GM, Berk M et al. Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs. EUROPEAN NEUROPSYCHOPHARMACOLOGY . 2022;60:91-99. doi: 10.1016/j.euroneuro.2022.05.002